I had an interesting discussion yesterday about the “antimicrobial pipeline” as part of the Global Leaders Group on Antimicrobial Resistance. When we talk about the antimicrobial pipeline, we’re referring to the dwindling number of new antimicrobial drugs that are currently in development. Antimicrobial research and development (R&D) has fallen by the wayside over the

The antibiotic development pipeline is drying up. More companies are abandoning the area because antibiotics are expensive to develop and license, but they are low profit drugs that we try to use as little as possible.

test

This is a big issue for human medicine, and was the focus of a lot of discussion at this

I’ve written (ranted?) about this before – namely the misuse of antimicrobials intended for treatment of aquarium fish in other species. Usually such posts are followed by a deluge of nasty emails along with a bunch of curious requests for links to fish antibiotic sellers (8% kickback available!).

Another sponsorship request came in this morning

How do I link all those? It’s not as big of a stretch as you might think, but it’s definitely getting into some theoretical components.

Dogs are unique from a Lyme disease perspective in that healthy individuals are very commonly tested.

Hundreds of thousands of dogs get tested every year for heartworm, and common heartworm

I’ve spent a lot of time in meetings listening to people debating whether to use the word “antibiotic” vs “antimicrobial.” I tend to stay out of those discussions because I don’t care too much either way.

  • Yes, they mean somewhat different things.
  • Yes, we want to be precise when writing guidance documents where the difference